Study Stopped
sufficient number of patients to meet objectives
Determination of the Optimal Spontaneous Breathing Trial During Weaning of Mechanical Ventilation
GLOBAL WEAN
1 other identifier
interventional
117
1 country
1
Brief Summary
Assessment and comparison of three spontaneous breathing trials in five specific profiles of intensive care unit and perioperative patients. A physiological cross over study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2019
CompletedFirst Posted
Study publicly available on registry
January 10, 2020
CompletedStudy Start
First participant enrolled
June 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2023
CompletedAugust 25, 2023
August 1, 2023
3 years
December 9, 2019
August 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Esophageal Pressure Time Product per minute (PTPes.min)
In cmH2O.s/min. Assessment of patient's inspiratory effort. Integration of esophageal swing pressure over time, performed with a second-generation balloon esophageal catheter, immediately before and after each spontaneous breathing trial, before and 20 min after extubation
Day one
Secondary Outcomes (2)
Esophageal Pressure Time Product per minute (PTPes.min)
Day two
Esophageal Pressure Time Product per minute (PTPes.min)
Day three
Other Outcomes (8)
Tidal impedance variation (TIV) assessed with Electrical Impedance Tomography
Day one
End Expiratory Lung Impedance (EELZ) assessed with Electrical Impedance Tomography
Day one
Global inhomogeneity index (GI) assessed with Electrical Impedance Tomography
Day one
- +5 more other outcomes
Study Arms (6)
T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0
EXPERIMENTALFirst T-piece trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min.
T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0
EXPERIMENTALFirst T-piece trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min.
PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piece
EXPERIMENTALFirst PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min.
PSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0
EXPERIMENTALFirst PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min.
PSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0
EXPERIMENTALFirst PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min.
PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piece
EXPERIMENTALFirst PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min.
Interventions
Spontaneous breath trial with a T-piece
Spontaneous breath trial with a pressure support ventilation of 7 cmH2O and no positive end expiratory pressure
Spontaneous breath trial without pressure support ventilation and positive end expiratory pressure, with a patient intubated and connected to the ventilator
Eligibility Criteria
You may qualify if:
- ICU patient with invasive mechanical ventilation for at least 24 hours
- Physician decision to extubate and all criteria for ventilatory weaning must be present
- Resolution of disease acute phase for which the patient was intubated
- Conscious patient (Richmond Agitation-Sedation Scale (RASS) \> 0), no sedation
- Good coughing effort, good swallowing, positive leak test (\> 12% of tidal volume (VT))
- No important secretions
- No respiratory acidosis, adequate oxygenation (PaO2 / FiO2 \> 150 mmHg and CPAP ≤ 8)
- Adequate pulmonary function (respiratory rate (RR) ≤ 35, negative inspiratory force (NIF) \> 20 cmH2O, RR/VT \< 105)
- Stable cardiovascular status (heart rate (HR) \< 140 bpm, systolic blood pressure \> 90 mmHg, no or minimal vasopressors)
- If severe brain injury, the VISAGE score must be ≥ 3 (visual pursuit, good swallowing, GCS \> 10)
You may not qualify if:
- Obese patients with BMI ≥ 35 kg/m2
- Contraindication for nasogastric tube or esophageal manometric balloon placement
- Refusal of study participation or to pursue the study by the patient, no consent
- Pregnancy or breastfeeding
- Absence of coverage by the French statutory healthcare insurance system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire Saint Eloi
Montpellier, Herault, 34000, France
Related Publications (2)
Mahul M, Jung B, Galia F, Molinari N, de Jong A, Coisel Y, Vaschetto R, Matecki S, Chanques G, Brochard L, Jaber S. Spontaneous breathing trial and post-extubation work of breathing in morbidly obese critically ill patients. Crit Care. 2016 Oct 27;20(1):346. doi: 10.1186/s13054-016-1457-4.
PMID: 27784322BACKGROUNDCapdevila M, De Jong A, Aarab Y, Vonarb A, Carr J, Molinari N, Capdevila X, Brochard L, Jaber S. Which spontaneous breathing trial to predict effort to breathe after extubation according to five critical illnesses: the cross-over GLOBAL WEAN study protocol. BMJ Open. 2023 Jul 12;13(7):e070931. doi: 10.1136/bmjopen-2022-070931.
PMID: 37438068DERIVED
Study Officials
- STUDY DIRECTOR
Samir Jaber, MD, PHD
Montpellier University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2019
First Posted
January 10, 2020
Study Start
June 15, 2020
Primary Completion
June 15, 2023
Study Completion
June 15, 2023
Last Updated
August 25, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 12 months after the main publication
- Access Criteria
- Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and institutional review board (IRB) review. Dataset will be shared after careful examination by the study board of investigators.
Individual patient data will be made available upon a reasonable request